Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1995 Jun;50(6):668–671. doi: 10.1136/thx.50.6.668

Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.

P Fernandez 1, A Torres 1, J M Miro 1, C Vieigas 1, J Mallolas 1, L Zamora 1, J M Gatell 1, M E Valls 1, R Riquelme 1, R Rodríguez-Roisin 1
PMCID: PMC1021269  PMID: 7638811

Abstract

BACKGROUND--Studies attempting to identify the prognostic factors that influence the outcome of Pneumocystis carinii pneumonia (PCP) in patients with AIDS using a multivariate analysis are few. In order to identify those prognostic factors amenable to medical intervention, univariate and multivariate analyses were performed on 102 patients with AIDS suffering a first episode of PCP. METHODS--One hundred and two consecutive patients with AIDS (51% drug abusers, 45% homosexuals, and 4% with other HIV risk factors) admitted to our institution between 1986 and 1989 whose respiratory infection was diagnosed by bronchoalveolar lavage were studied prospectively. RESULTS--The overall mortality was 28%, rising to 79% in those patients who required mechanical ventilation. According to univariate analysis the following variables were related to a poor prognosis: age > 35 years; risk factor for HIV infection other than drug abuse; and AIDS diagnosis confirmed before 1988; PaO2 < 8 kPa at admission; severe acute respiratory failure on admission (PaO2/FIO2 < 20 kPa); mechanical ventilation; antibiotic therapy for PCP other than trimethoprim-sulphamethoxazole; multiple microbial pulmonary infection; serum lactate dehydrogenase (LDH) > 22.5 mukat/l on admission; serum albumin level < 30 g/l. Multivariate analysis showed that only mechanical ventilation was independently associated with a poor outcome. CONCLUSIONS--The mortality of AIDS patients presenting with a first episode of PCP before 1990 was high (28%). The main prognostic factor associated with poor outcome was the requirement for mechanical ventilation due to severe acute respiratory failure.

Full text

PDF
668

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson C. A., Spear J., Hines D., Pottage J. C., Jr, Kessler H. A., Trenholme G. M. Combined APACHE II score and serum lactate dehydrogenase as predictors of in-hospital mortality caused by first episode Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis. 1991 Aug;144(2):319–323. doi: 10.1164/ajrccm/144.2.319. [DOI] [PubMed] [Google Scholar]
  2. Bozzette S. A., Sattler F. R., Chiu J., Wu A. W., Gluckstein D., Kemper C., Bartok A., Niosi J., Abramson I., Coffman J. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1990 Nov 22;323(21):1451–1457. doi: 10.1056/NEJM199011223232104. [DOI] [PubMed] [Google Scholar]
  3. Brenner M., Ognibene F. P., Lack E. E., Simmons J. T., Suffredini A. F., Lane H. C., Fauci A. S., Parrillo J. E., Shelhamer J. H., Masur H. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1987 Nov;136(5):1199–1206. doi: 10.1164/ajrccm/136.5.1199. [DOI] [PubMed] [Google Scholar]
  4. Dohn M. N., Baughman R. P., Vigdorth E. M., Frame D. L. Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1992 Dec;152(12):2465–2470. doi: 10.1001/archinte.152.12.2465. [DOI] [PubMed] [Google Scholar]
  5. Efferen L. S., Nadarajah D., Palat D. S. Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective. Am J Med. 1989 Oct;87(4):401–404. doi: 10.1016/s0002-9343(89)80821-6. [DOI] [PubMed] [Google Scholar]
  6. Friedman Y., Franklin C., Rackow E. C., Weil M. H. Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest. 1989 Oct;96(4):862–866. doi: 10.1378/chest.96.4.862. [DOI] [PubMed] [Google Scholar]
  7. Garay S. M., Greene J. Prognostic indicators in the initial presentation of Pneumocystis carinii pneumonia. Chest. 1989 Apr;95(4):769–772. doi: 10.1378/chest.95.4.769. [DOI] [PubMed] [Google Scholar]
  8. Hopewell P. C. Pneumocystis carinii pneumonia: diagnosis. J Infect Dis. 1988 Jun;157(6):1115–1119. doi: 10.1093/infdis/157.6.1115. [DOI] [PubMed] [Google Scholar]
  9. Kohn H. I., Fry R. J. Radiation carcinogenesis. N Engl J Med. 1984 Feb 23;310(8):504–511. doi: 10.1056/NEJM198402233100807. [DOI] [PubMed] [Google Scholar]
  10. Kovacs J. A., Hiemenz J. W., Macher A. M., Stover D., Murray H. W., Shelhamer J., Lane H. C., Urmacher C., Honig C., Longo D. L. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984 May;100(5):663–671. doi: 10.7326/0003-4819-100-5-663. [DOI] [PubMed] [Google Scholar]
  11. Kovacs J. A., Masur H. Pneumocystis carinii pneumonia: therapy and prophylaxis. J Infect Dis. 1988 Jul;158(1):254–259. doi: 10.1093/infdis/158.1.254. [DOI] [PubMed] [Google Scholar]
  12. LaRocco A., Jr, Amundson D. E., Wallace M. R., Malone J. L., Oldfield E. C., 3rd Corticosteroids for Pneumocystis carinii pneumonia with acute respiratory failure. Experience with rescue therapy. Chest. 1992 Sep;102(3):892–895. doi: 10.1378/chest.102.3.892. [DOI] [PubMed] [Google Scholar]
  13. Mallolas J., Zamora L., Gatell J. M., Miró J. M., Vernet E., Valls M. E., Soriano E., SanMiguel J. G. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS. 1993 Jan;7(1):59–64. [PubMed] [Google Scholar]
  14. Mallolas J., Zamora L., Gatell J. M., Miró J. M., Vernet E., Valls M. E., Soriano E., SanMiguel J. G. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS. 1993 Jan;7(1):59–64. [PubMed] [Google Scholar]
  15. Montaner J. S., Russell J. A., Lawson L., Ruedy J. Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A potential role for systemic corticosteroids. Chest. 1989 Apr;95(4):881–884. doi: 10.1378/chest.95.4.881. [DOI] [PubMed] [Google Scholar]
  16. Murray J. F., Matthay M. A., Luce J. M., Flick M. R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  17. Peruzzi W. T., Skoutelis A., Shapiro B. A., Murphy R. M., Currie D. L., Cane R. D., Noskin G. A., Phair J. P. Intensive care unit patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia: suggested predictors of hospital outcome. Crit Care Med. 1991 Jul;19(7):892–900. doi: 10.1097/00003246-199107000-00012. [DOI] [PubMed] [Google Scholar]
  18. Sadaghdar H., Huang Z. B., Eden E. Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS. Evidence for the development of high-permeability pulmonary edema. Chest. 1992 Jul;102(1):63–69. doi: 10.1378/chest.102.1.63. [DOI] [PubMed] [Google Scholar]
  19. Stover D. E., White D. A., Romano P. A., Gellene R. A., Robeson W. A. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):429–437. doi: 10.1016/0002-9343(85)90334-1. [DOI] [PubMed] [Google Scholar]
  20. Wachter R. M., Russi M. B., Bloch D. A., Hopewell P. C., Luce J. M. Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units. Am Rev Respir Dis. 1991 Feb;143(2):251–256. doi: 10.1164/ajrccm/143.2.251. [DOI] [PubMed] [Google Scholar]
  21. Wharton J. M., Coleman D. L., Wofsy C. B., Luce J. M., Blumenfeld W., Hadley W. K., Ingram-Drake L., Volberding P. A., Hopewell P. C. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med. 1986 Jul;105(1):37–44. doi: 10.7326/0003-4819-105-1-37. [DOI] [PubMed] [Google Scholar]
  22. el-Sadr W., Simberkoff M. S. Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am Rev Respir Dis. 1988 Jun;137(6):1264–1267. doi: 10.1164/ajrccm/137.6.1264. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES